An Open-Label Expanded Access Study of Lapatinib and Capecitabine Therapy in Subjects with ErbB2 Overexpressing Locally Advanced or Metastatic Breast Cancer

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2006
This article has no abstract
Epistemonikos ID: e90c06b8b07ac254b34c6c9785f70016c17f85ef
First added on: Jan 21, 2025